Mouse models for Cln3 deficiency showed a relatively late onset of symptoms (6–12 mo), including several hallmarks of Batten disease such as neurodegeneration and lipofuscin accumulation (6, 7, 16). Here, CLN3 is linked to juvenile neuronal ceroid lipofuscinosis.